Literature DB >> 15943972

Second nature: biological functions of the Raf-1 "kinase".

Manuela Baccarini1.   

Abstract

More than 20 years ago, Raf was discovered as a cellular oncogene transduced by transforming retroviruses. Since then, the three Raf isoforms have been intensively studied, mainly as the kinases linking Ras to the MEK/ERK signaling module. As this pathway is activated in human cancer, the Raf kinases are considered promising therapeutic targets, and we have learned a lot about their regulation, targets, and functions. Do they still hold surprises? Recent gene targeting studies indicate that they do. This review focuses on the regulation and biology of the best-studied Raf isoform, Raf-1, in the context of its kinase-independent functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15943972     DOI: 10.1016/j.febslet.2005.03.024

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  49 in total

Review 1.  GnRH signaling, the gonadotrope and endocrine control of fertility.

Authors:  Stuart P Bliss; Amy M Navratil; Jianjun Xie; Mark S Roberson
Journal:  Front Neuroendocrinol       Date:  2010-05-06       Impact factor: 8.606

Review 2.  Organization of the ENaC-regulatory machinery.

Authors:  Rama Soundararajan; Ming Lu; David Pearce
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-04-16       Impact factor: 8.250

Review 3.  Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis.

Authors:  André L Mihaljevic; Christoph W Michalski; Helmut Friess; Jörg Kleeff
Journal:  Langenbecks Arch Surg       Date:  2010-03-18       Impact factor: 3.445

4.  In silico identification of novel kinase inhibitors by targeting B-Raf(v660e) from natural products database.

Authors:  Zi-jie Wang; Zhi-ning Wan; Xu-dong Chen; Chuan-fang Wu; Guo-long Gao; Rong Liu; Zheng Shi; Jin-ku Bao
Journal:  J Mol Model       Date:  2015-04-02       Impact factor: 1.810

Review 5.  MAP kinase pathways: the first twenty years.

Authors:  Joseph Avruch
Journal:  Biochim Biophys Acta       Date:  2006-11-15

6.  Inhibition of Raf-1 alters multiple downstream pathways to induce pancreatic beta-cell apoptosis.

Authors:  Emilyn U Alejandro; James D Johnson
Journal:  J Biol Chem       Date:  2007-11-15       Impact factor: 5.157

7.  Kinase regulation by hydrophobic spine assembly in cancer.

Authors:  Jiancheng Hu; Lalima G Ahuja; Hiruy S Meharena; Natarajan Kannan; Alexandr P Kornev; Susan S Taylor; Andrey S Shaw
Journal:  Mol Cell Biol       Date:  2014-10-27       Impact factor: 4.272

8.  PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells.

Authors:  Ruth Halaban; Wengeng Zhang; Antonella Bacchiocchi; Elaine Cheng; Fabio Parisi; Stephan Ariyan; Michael Krauthammer; James P McCusker; Yuval Kluger; Mario Sznol
Journal:  Pigment Cell Melanoma Res       Date:  2010-02-10       Impact factor: 4.693

9.  Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1.

Authors:  Astrid Rohrbeck; Jürgen Borlak
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240

10.  Protein farnesylation-dependent Raf/extracellular signal-related kinase signaling links to cytoskeletal remodeling to facilitate glucose-induced insulin secretion in pancreatic beta-cells.

Authors:  Anjaneyulu Kowluru; Rajakrishnan Veluthakal; Christopher J Rhodes; Vasudeva Kamath; Ismail Syed; Brandon J Koch
Journal:  Diabetes       Date:  2010-01-13       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.